Quest Diagnostics Dividends
| DGX Stock | USD 166.00 0.62 0.37% |
Quest Diagnostics' past performance could be the main factor of why investors trade Quest Diagnostics Incorporated stock today. Investors should clearly understand every aspect of the Quest Diagnostics dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Quest Diagnostics' dividend schedule and payout information. Quest Diagnostics Incorporated dividends can also provide a clue to the current valuation of Quest Diagnostics.
One of the primary advantages of investing in dividend-paying companies such as Quest Diagnostics is that dividends usually grow steadily over time. As a result, well-established companies that pay dividends typically increase their dividend payouts yearly, which many long-term traders find attractive. Quest |
Investing in dividend-paying stocks, such as Quest Diagnostics Incorporated is one of the few strategies that are good for long-term investment. Ex-dividend dates are significant because investors in Quest Diagnostics must own a stock before its ex-dividend date to receive its next dividend.
Recent Quest Diagnostics Dividends Paid (per share)
Dividends Paid |
| Timeline |
Quest Diagnostics Expected Dividend Income Per Share
Dividend payment represents part of Quest Diagnostics' profit that is distributed to its stockholders. It is considered income for that tax year rather than a capital gain. In other words, a dividend is a prize given to shareholders for investing in Quest Diagnostics. Quest Diagnostics' board of directors can pay out dividends at a planned frequency, such as monthly or quarterly.
$1.91 Bottom Scenario | $1.95 | $1.98 Top Scenario |
One Year
Quest Diagnostics Incorporated expected dividend income per share adjusted for ongoing price standard deviation
Quest Diagnostics Past Distributions to stockholders
| 29th of January 2025 | ||
| 21st of October 2024 | ||
| 22nd of July 2024 | ||
| 22nd of April 2024 | ||
| 31st of January 2024 | ||
| 23rd of October 2023 | ||
| 25th of July 2023 | ||
| 24th of April 2023 |
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quest Diagnostics. If investors know Quest will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quest Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Quest Diagnostics is measured differently than its book value, which is the value of Quest that is recorded on the company's balance sheet. Investors also form their own opinion of Quest Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Quest Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quest Diagnostics' market value can be influenced by many factors that don't directly affect Quest Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quest Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Quest Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quest Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.